HUM logo

HUM

Humana Inc.
HealthcareHealthcare PlansMomentum
$290.95 · 15min delay
β 0.68

A steady large-cap momentum story trading near fair value.

52-wk low $163.1152-wk high $315.35

Mkt Cap

$34.93B

P/E

PEG

1.56

P/B

1.99

Dividend

1.29%

ROE

6.3%

About the business

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Price history

Loading…

Drag across the chart to select a custom period — all analysis below refocuses to that window.

Premium view

Normalized peer comparison

Overlay this stock against up to five peers, rebased to 100, with synchronized range switching.

Premium view

What matters now — AI brief

A 90-second summary grounded in Prism's framework scores and the latest price action. Members unlock this automatically.

News & events

Next earnings

Wed, Jul 29 · consensus EPS $6.51 · last actual $10.31

Premium view

Full decision report

Every framework verdict, the structural concerns, the investment case, the decision-boundary levers, and your personal thesis journal — only for members.